- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 25.68M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $67.16M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $66.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $437.76M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $358.9M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $565.22M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $524.1M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $531.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $475.44M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $778.57M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $745.51M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 26.28M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $7.06M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.97M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $8.98M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $51.27M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $71.17M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $189.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $199.14M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $42.41M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$136K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$4.7M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $39.57M |